Baxter International Inc. (NYSE:BAX) today announced its financial results for the fourth quarter of 2011, and provided its financial outlook for the first quarter and full-year 2012. ... read more

Baxter International Inc. (NYSE:BAX) today provided an update on its clinical program evaluating the use of its GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] (marketed as KIOVIG outside ... read more

Baxter International Inc. (NYSE:BAX) announced today that Jean-Luc Butel has been appointed corporate vice president and president, international, reporting to Robert L. Parkinson, Jr., chairman and chief ... read more

Baxter International Inc. (NYSE:BAX) today announced that the company has submitted a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of ... read more

Baxter International Inc. (NYSE: BAX) today announced the dosing of the first patients in a Phase I clinical trial of its lead investigational candidate, BAX 855, a longer-acting ... read more

Baxter International Inc. (NYSE: BAX) has been notified of an unsolicited “mini-tender” offer by TRC Capital Corporation to purchase up to 2 million shares, or approximately 0.35 percent, ... read more

Baxter International Inc. (NYSE:BAX) and Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) today announced that they have entered into a global collaboration to develop and commercialize follow-on biologic products, ... read more

Baxter International Inc. (NYSE: BAX) announced today that it will present at the 30th Annual J.P. Morgan Health Care Conference on Tuesday, January 10, 2012, at 2:30 p.m. ... read more

Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ADVATE [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for routine prophylaxis to ... read more

Baxter International Inc. (NYSE: BAX) demonstrated its commitment to volunteerism and product donation as well as to environmentally-conscious practices and corporate social responsibility ... read more

Baxter International Inc. (NYSE:BAX) and Synovis Life Technologies, Inc. (NASDAQ:SYNO) today announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical ... read more

Baxter International Inc. (NYSE: BAX) announced today that it will present at the 23rd Annual Piper Jaffray Health Care Conference on Tuesday, November 29, 2011, at 12:00 p.m. ... read more

The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.335 per Baxter common share, payable on January 4, 2012 to shareholders of ... read more

Baxter International Inc. (NYSE: BAX) today announced the presentation of its phase III study data for HyQ, an investigational combination immunoglobulin (IG) product for use in patients with ... read more

Baxter International Inc. (NYSE:BAX) announced today the European launch of NUMETA (emulsion for infusion). NUMETA was introduced at the 22nd Annual European Society of Pediatric and Neonatal Intensive ... read more

Results from an investigator-initiated study, which evaluated whether prophylactic use of FEIBA [Anti-inhibitor Coagulant Complex] can achieve a decrease in the frequency of joint and other bleeding events ... read more

Baxter International Inc. (NYSE: BAX) announced today that it will present at the Credit Suisse 2011 Healthcare Conference on Wednesday, November 9, 2011, at 11:00 a.m. (CT) or ... read more

Baxter International Inc. (NYSE:BAX) today reported third quarter net income of $576 million, an increase of 10 percent from $525 million reported in the third quarter of 2010. ... read more

Baxter International Inc. today announced initiation of a Phase III clinical trial to evaluate the safety and effectiveness of BAX 111, Baxter’s investigational recombinant von Willebrand factor (rVWF), ... read more

The Honor Society of Nursing, Sigma Theta Tau International (STTI), is pleased to announce that Kathleen R. Stevens, EdD, MS, RN, ANEF, FAAN, will receive The Baxter International ... read more